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1. Introduction 
Since the discovery that certain viruses can induce 
malignant tumours in experimental nimals and can 
transform cells in culture giving them oncogenic pro- 
perties, the study of such viruses has become one of the 
most interesting and fruitful approaches tothe control 
of human cancer. The viral etiology of animal eukae- 
mias and possibly a human lymphoma gives support 
for this view. The colloquium provided a report on cur- 
rent progress and emphasised that molecular biology 
is at last being put to use in medicine. For none of the 
exciting results described, particularly with regard to 
the diagnosis of human leukaemias by RNA-dependent 
DNA polymerase assays and the activity of rifampicin 
derivatives to inhibit this viral enzyme, would have been 
possible without knowledge of cellular and viral macro- 
molecular mechanisms of replication and information 
transfer. The advances that have been made recently in 
this complex field, which are reported below, are the 
product of many years of virological and biochemical 
work. When such results are presented elaborate no- 
menclature is used and conceptual assumptions are made 
that scientists in other fields find difficulty in under- 
standing. Perhaps a discussion of such words and con- 
cepts would be useful before a report on the meeting. 
Oncogenic viruses, that is viruses which can trans- 
form (convert) normal cells in vivo or in vitro into "can- 
* The full proceedings of this meeting will be published in: 2nd 
Lepetit Colloquium on Biology and Medicine, The Biology 
of Oncogenic Viruses, ed. L. Silvestri (North-Holland, 1971) 
in press. 
cer" cells which multiply and proliferate in an uncon- 
trolled manner, are classified as to whether they contain 
DNA or RNA. The genetic information carried in the 
nucleic acid of the virus particle (virion) is termed the 
virus genome. Although other DNA-containing viruses 
have been shown to cause tumours in experimental 
animals, current research into the mechanism of onco- 
genesis by DNA viruses is almost entirely restricted to 
simian virus strain 40 (SV40) isolated originally from 
monkey kidney cells, and polyoma, originally isolated 
from mouse tumour tissue. There are several reasons 
why these two are so popular. They can be grown easily 
and will transform cells without difficulty in the labor- 
atory. Also they are both small and their DNA pro- 
bably does not code for more than ten small proteins. 
Yet in this small piece of nucleic acid lies the informa- 
tion to cause a malignant tumour. When a virus of 
this type enters a cell, it can either grow lytically, that 
is, multiply within and eventually l se and destroy 
the cell to liberate daughter particles, or it can trans- 
form the cell. In the latter response, the viral DNA is 
integrated into the DNA of the host cell chromosomes. 
The viral DNA becomes part of the chromosomal 
DNA and is replicated uring the normal process of 
cell mitosis. Thus the cell has a covalently fixed mole- 
cular parasite which is reproducing itself by making 
the cell multiply repeatedly. In the laboratory, normal 
cells grow on the wall of the culture dish to form an 
even monolayer and then stop dividing. In this state 
they are said to be confluent. The same cells when 
transformed grow in multilayered heaps (foci) on the 
dish wall. 
The probable molecular biology of these processes 
North.Holland Publishing Company - Amsterdam 8 3 
Volume 12, number 2 FEBS LETTERS December 1970 
may be summarized as follows. After entering the cell, 
the virus particle loses its protein capsid (outer coat) 
and the viral DNA passes into the nucleus. There host 
DNA-dependent RNA polymerase binds to the viral 
DNA, probably at a specific promoter (the site at which 
RNA synthesis i initiated) and transcribes the DNA, 
forming complementary viral RNA. The latter then pas- 
ses back into the cytoplasm to be translated into viral 
specific protein on the cell ribosomes. One of these 
proteins is known and is called the tumour antigen 
(T-antigen). It can be detected immunologicaUy. Depen- 
ding on the nature of the cell or other factors, the lytic 
or transformation i teraction may occur. In the lytic 
response, viral DNA is replicated presumably by viral 
enzyme(s) and packaged with virus capsid protein to 
form new virions. If transformation is elicited the viral 
DNA is integrated by a mechanism as yet unclear. All 
viral specific activities which happen in the cell before 
viral DNA replication begins are termed early functions. 
Those occuring during replication are called late. Be- 
sides the induction of T-antigen, other early functions 
are: stimulation of host DNA synthesis; a change in the 
host cell surface properties; and stimulation of the syn- 
thesis of certain host cell enzymes concerned with 
DNA replication. 
Numerous RNA tumour viruses are under study and 
some, notably the Schmidt-Ruppin strain of Rous sar- 
coma virus, will transform cells in culture. The mole- 
cular biology of these viruses has become more clear 
recently. The RNA replication of RNA bacteriophages 
and many RNA viruses, such as influenza, is mediated 
by an RNA-dependent RNA polymerase and proceeds 
by transcription of the viral RNA to form a second 
strand of RNA bound to the first. This is called the 
double strand viral RNA intermediate. The second 
strand, termed minus strand, in then replicated to form 
the daughter strands which are identical with the vir- 
ion RNA. However, the work of Temin and others has 
shown that RNA tumour virus nucleic acid is replicated 
by an RNA-dependent DNA polymerase which produces 
an RNA-DNA hybrid (containing single stranded vir- 
al specific DNA), then a single stranded viral DNA, and 
finally, double stranded viral DNA. This viral DNA pos- 
sibly may then act as template for production of daugh- 
ter viral RNA or may be integrated into host cell chro- 
mosomal DNA during transformation of the cell. Pro- 
duction of daughter viral RNA from the integrated DNA 
also almost certainly occurs. 
The meeting was divided into sessions at which 
either DNA or RNA tumour viruses were discussed. 
We shall start with the DNA virus reports. 
2. Biochemical studies on the gene products of 
DNA viruses responsible for transformation 
As the initial product of gene expression is RNA, 
several papers dealt with viral RNA synthesis, in vitro, 
in the lytic response, and in transformed cells. Fol- 
lowing this, viral protein synthesis was discussed. 
2.1. In vitro transcription 
Transcription of SV40 DNA by Escherichia coli 
RNA polymerase, as described by H. Westphal (Cold 
Spring Harbor), can proceed along the entire genome 
without release, although rho, the bacterial factor 
which causes pecific termination of RNA synthesis 
at the end of a gene, slightly reduces the size of the 
product RNA. In agreement with this finding of poly- 
cistronic transcription, E. Winocour (Weizmann In- 
stitute) reported electron microscope studies which 
showed that SV40 DNA binds only one molecule of 
monkey or rat RNA polymerase per molecule DNA in- 
dicating that only one promoter site for initiating RNA 
synthesis i present. So it would appear that the whole 
of the viral DNA is transcribed in one pass of the en- 
zyme, producing apiece of RNA that is the same 
length as the DNA. 
2.2. Viral transcription during the lyric response and 
in the integrated state 
The viral RNA species detectable in cells lytically 
infected with SV40 have been characterised with re- 
spect o size and time of synthesis after infection by 
M. Herzberg (Weizmann Institute) and E. Winocour 
and by S. Tonegawa et al. (Salk Institute). The size 
of the RNA produced correlates well with the size of 
some of the viral proteins formed at the same time 
after infection. So it seems likely that these RNA 
species are in fact the viral RNA messengers that are 
translated to protein on the cell ribosomes. Cells trans- 
formed by SV40 synthesise viral RNA which is found 
initially in the high molecular weight nucleoplasmic 
RNA fraction. J.E. Darnell and T.R. Wall (Columbia) 
showed this to consist mainly of cell RNA with a 
10-25% content of viral RNA. Tonegawa reported 
that the viral RNA is degraded to half genome size 
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pieces before transfer to the cytoplasm. 
All these results bode well for the possible isolation 
and purification of the viral mRNAs. Of particular im- 
portance is the isolation of the messengers necessary 
for viral integration and its maintenance. 
2.3. Virus specified proteins 
Isolation of the virus-specified proteins whose ac- 
tion mediates transformation is still a pipedream to 
most oncogeneticists. One therefore cannot but admire 
the courage of L.V. Crawford (Imperial Cancer Re- 
search Fund), B. Hirt, R.F. Gesteland and G.M. Rubin 
(Cold Spring Harbor) in having the temerity to attempt 
to synthesise such proteins in vitro. Early results look 
encouraging in that a combined RNA and protein syn- 
thesising system containing RNA polymerase, ribosomes 
and factors from E. coli will make large polypetides, 
some up to 35,000 daltons, coded for entirely by SV40 
or polyoma DNA. The polypeptides are being charac- 
terised by tryptic digestion and electrophoresis. The 
electrophoretic patterns they yield will then be com- 
pared with those given by virion and in vivo produced 
viral proteins. 
3. Cell surface changes induced during transformation 
by DNA viruses 
cells transformed by a temperature s nsitive (ts) 
mutant of polyoma, ts-3, the state of the plasma 
membrane was controlled by the mutant gene. At 
permissive temperatures which allow expression of the 
gene the receptors were exposed, whilst at non-per- 
missive temperatures which inactivate the gene they 
were covered; switching from one condition to the 
other could be demonstrated by altering the growth 
temperature. However, J.F. Sambrook (Cold Spring 
Harbor) described the isolation of mutant ransformed 
cells which had acquired resistance to concanavalin A,
a substance with similar properties to wheat germ ag- 
glutinin, showing that these cells have regained genetic 
control of this feature of the cell surface without af- 
fecting the transformed state. 
A difference in the topography of the agglutination 
sites on the cell surface was found by Leo Sachs (Weiz- 
mann Institute) and he claimed that all carcinogens, 
chemical or viral, produce the same changes. Biochem- 
ical changes in the cell plasma membrane on transfor- 
mation have been detected. Rose Sheinin (Toronto) 
showed that transformation causes an increase in the 
amount of basic protein present and a loss of 2 of the 
4 gangliosides detectable. Also I.A. Macpherson (Im- 
perial Cancer Research Fund) found that two glyco- 
lipids, aminoglycolipid and ceramide trihexoside, are 
similarly lost. 
Cell surface changes are induced early after infec- 
tion and are essential if the cell is to exhibit oncogenic 
growth. The demonstration by Max Burger and co- 
workers (Princeton) that wheat germ agglutinin reacts 
with cell membrane receptor sites exposed uring in- 
fection and transformation by polyoma or SV40 has 
provided an important tool to examine the role of the 
cell membrane in oncogenesis. Trypsin treatment ex- 
poses the receptors in normnl cell membranes. Burger 
presented results which indicate that receptor ex- 
posure is linked with cell DNA replication and that 
the agglutinin, which kills the cells, acts by sticking 
them together thereby preventing essential movement. 
He suggests that the normal receptor-covering material 
stops growth of confluent cells in a similar way. When 
this material is lost during transformation the multi- 
layer heaped growth characteristic of oncogenic ells 
can occur, as the outer membranes do not then inter- 
act. 
Walter Eckhart (Salk Institute) reported that in 
4. Genetic analysis of the virion and of the intergrated 
viral genome of tumour viruses 
Genetic analysis is a powerful tool with which to 
define the genes responsible for transformation a d 
study their mode of action. Unfortunately the relative 
inefficiency of the growth of cells in culture and the 
growth of virus in cells compared to bacteria-bacterio- 
phage systems have made its application difficult. How- 
ever, progress i  being made. Temperature s nsitive 
and host range mutants have been discovered. 
4.1. Temperature sensitive ( ts ) mutants 
Eckhart described the range and properties of 
available ts mutants of polyoma which do not repli- 
cate their DNA at the non-permissive t mperature 
and showed that certain cellular characteristics are 
controlled by these mutant viral genes both during 
infection and during the maintenance of the trans- 
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formed state; for example, the cell surface changes 
described earlier. Tumor viruses containing RNA have 
yielded ts mutants affecting their alibity to transform 
cells. Reports of their isolation came for the Schmidt- 
Ruppin strain of Rous sarcoma virus by P.Vigier 
(Radium Institute) and by G.S. Martin (Berkeley) 
and for another avian sarcoma virus by Peter Vogt 
(Seattle). Evidence concerning the nature of the ts-a 
gene of polyoma was presented by Jesse Summers 
(Salk Institute). The gene may control the maintenance 
of the integrated state of the viral genome since, if 
grown at the non-permissive t mperature, ceils prev- 
iously transformed by this mutant will yield virus if 
fused to mouse cells at the permissive temperature. This 
phenomenon is not seen with cells transformed by wild 
type virus or when the polyoma ts-a transformed cells 
are cloned at the permissive temperature. Attempts by 
A. Ishikawa and G. di Mayorca (Nebraska) to set up an 
efficient recombination system to map the ts mutants 
of polyoma proved unsuccessful though recombination 
was demonstrated. 
4.2. Host range mutants 
Mutants of polyoma which show lytic growth in 
transformed mouse cells but which do not grow in nor- 
mal cells have been isolated by Thomas Benjamin 
(New York Public Health Research Institute). Happily, 
they all show loss of transforming ability as well as 
lyric growth in normal mouse cells. This indicates that 
the mutations lie in a gene whose activity is needed for 
lyric growth and for integration and which is also ex- 
pressed uring the maintenance of the integrated viral 
DNA. Benjamin reported that loss of this gene activity 
did not prevent adsorption, penetration, uncoating, 
T-antigen induction, or stimulation of host cell DNA 
synthesis when non-permissive, that is, normal cells 
were infected with the mutants. However, no cell 
surface changes are induced and the virus capsid protein 
is not made. 
5. Studies on DNA virus replication, integration and 
rescue 
Evidence concerning the mechanism of polyoma 
DNA replication was presented by Pierre Bourgaux 
(Sherbrook University, Quebec). Polyoma DNA, which 
is circular, is replicated at a single growing point which 
travels along the DNA unidirectionally. This generates 
an intermediate r sembling two circles of DNA partial- 
ly fused together such that a portion of the DNA is 
common to both circles. Elegant electron micrographs 
were shown of the replicative intermediate before and 
after treatment with an endonuclease from Neurospora 
crassa. This enzyme is highly specific for single stranded 
nucleic acid. The endonuclease cleaved the intermedi- 
ate first at one branch point and then at the other. 
Studies on the use of the cell fusion technique to 
test the dependence on host chromosomes of the lytic 
or transforming response of polyoma in mouse-hamster 
cell hybrids are underway in Claudio Basilico's labor- 
atory (New York University). As found previously, 
permissiveness to lytic growth is dominant, hat is, 
these hybrids almost always support lyric growth and 
are not transformed. In hybrids of transformed hamster 
and normal mouse cells, superinfection f the hybrid 
cells with mutant s-a polyoma virus appears to rescue 
the transforming virus, though recombination effects, 
that is, exchange of genes between the integrated and 
infecting virus DNA, are difficult to rule out. Rescue, 
which means excision of integrated viral DNA from 
the host chromosome, of SV40 from transformed ham- 
ster cells may involve a helper virus. F.C. Jensen (Wistar 
Institute) reported that a new foamy virus (hamster syn- 
cytia forming virus) always appears with the rescued 
SV40. Intracellular factors affecting the replication of 
SV40 were discussed by S. Kit (Baylor) and Roland Cas- 
singena (ViUejuif) and the confused state of knowledge 
concerning the regulation of interferon production 
and action was described by C. Chany (Villejuif). 
6. Rifampicin, an anti-transformation drug? 
On the anti-DNA tumour virus drug scene, J.H. 
Subak-Sharpe (Glasgow) reported a greatly depressed 
polyoma transformation frequency with rifampicin- 
resistant BHK cells in the presence of the drug. This 
might indicate that the aminopiperazine family of 
drugs has some activity against oncogenic transfor- 
mation that could be enhanced by a proficient organic 
chemist. An interesting and possibly highly significant 
finding was presented by L. Thiry (Pasteur, Brussels). 
The AP4 derivative of rifampicin is able to reduce the 
Epstein-Barr virus antigen by over 80% in a Burkitt 
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cell line derived from human Burkitt's lymphoma tis- 
sue. The DNA-containing Epstein-Barr virus, a type of 
herpes virus, may be the causal agent of this human 
cancer. 
7. The mechanism of oncogenesis caused by RNA 
tumour viruses 
Probably the major scientific event of the year was 
the discovery of RNA-dependent DNA polymerase activ- 
ity in the virions of many RNA tumour viruses. The val- 
idity of H.M. Temin's ideas on the role of virus-specific 
DNA in the replication and integration into host chro- 
mosomes of the viral nucleic acid is now generally ac- 
cepted. At this meeting "Le D61uge" continued. 
7.1. Role of RNA-dependent DNA polymerase in
viral integration and replication 
David Baltimore (M.I.T.), M. Green (St. Louis) and 
S. Spiegelman (Columbia) each described the latest 
properties Of their respective polymerase enzyme(s) 
which synthesise double strand viral DNA from single 
strand viral RNA. The consensus appears to be that a 
single enzyme or multienzyme complex catalyses the 
reaction, with RNA-DNA hybrid and single strand 
DNA as intermediates. This was demonstrated by Balti- 
more with the mouse leukaemia virus system utilising 
the N. crassa endonuclease which specifically breaks 
down single stranded nucleic acid. Here the polymerase(s) 
act on viral RNA to produce a complex containing all 
the above intermediates and products. When treated 
with the endonuclease, the complex yields an RNA- 
DNA hybrid and double strand viral DNA. Green showed 
similar results using hydroxyapatite o separate single 
and double stranded DNA and RNA-DNA hybrid. In 
all cases the final products are small pieces of DNA 
which sediment at less than 10 S. It was left to Peter 
Duesberg and coworkers (Berkeley), however, to clear 
up the troublesome problems of the extent of virus 
specific DNA in the DNA product and of the extent 
of RNA transcription - is the whole viral genome trans- 
cribed into DNA or just a small portion? Firstly, the 
RNA-DNA hybrid of the Schmidt-Ruppin Rous sar- 
coma virus, after treatment with RNase, was shown 
to have a density in gradients close to that calculated 
for a complete double strand RNA-DNA hybrid. Since 
RNase breaks down single stranded RNA, the majority 
of the DNA present must be in the hybrid form (sin- 
gle stranded DNA could easily be distinguished at a 
lower density). Secondly, in saturation studies, 60-70% 
of the RNA strand could be annealed with DNA indi- 
cating extensive transcription of the viral genome. The 
ribbon to tie up this neat package could be a ligase 
activity which would link up the bits of viral DNA to 
make a complete viral DNA genome. This could then 
be used for infection, repfication, and integration stu- 
dies. Unfortunately the small size range could be due 
to contamination of the in vitro system with a cellular 
endonuclease artifactuaUy degrading the DNA product 
to the small pieces observed. 
G.J. Todaro (Bethesda) questioned the belief that 
the RNA-dependent DNA polymerase system is unique 
to tumour viruses ince he has also found the activity 
in visna and in primate syncytia forming virus (foamy) 
type 3. A voice in the wilderness was that of L.J.L.G. 
van Griensven (St. Louis Hospital, Paris) who dared to 
suggested that an RNA tumour virus might replicate 
not via DNA but through a double stranded viral RNA 
intermediate. Though out of fashion this summer, his 
group have isolated such material from cells infected 
with mouse sarcoma virus and have shown that inter- 
feron inhibits its production and the formation of com- 
plete virus particles. This would not be expected if a 
DNA intermediate were involved. The paper, however, 
drew heavy criticism since little is known of the mode 
of action of interferon and the results could perhaps 
be explained by cellular changes induced by the anti- 
viral agent. Also, Temin pointed out that interferon 
has little effect on cell transformation by these viruses. 
N. Biswal and M. Benyesh-Melnick (Baylor), with feet 
firmly in both camps, reported that double strand viral 
RNA can be demonstrated in cells transformed and in- 
fected with the murine sarcoma-murine leukaemia 
virus complex, the virions of which contain DNA, in 
addition to the RNA genome, which is complementary 
to the viral RNA. They suggest that whilst transfor- 
mation is DNA dependent, replication is not. 
7.2. Clinical approach 
Perhaps the most spectacular chievement reported 
at the colloquium was the clinical application of these 
findings. S. Spiegelman described 9 cases of untreated 
human leukaemia (the total examined so far) in which 
this probably unique viral polymerase could be detected 
in the membrane fraction of blood buffy coat cells 
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(leukocytes). Tests on 30 controls, 10 normal and 20 
from patients with a non-malignant leukocyte pro- 
liferation, were all negative. A clear cut result, posit- 
ive or negative, was obtained in all tests. The assay can 
be performed on as little as 5 ml of blood and uses poly 
dT:rA or poly dC:dG as template for the enzyme. The 
use of the technique as a diagnostic tool is therefore 
well on the way to being established. Possibly a more 
meaningful test would be to assay the blastoid cells 
in the bone marrow and this approach isbeing ex- 
amined currently. 
One of the hopes promoted by Temin's prediction 
and discovery is that drugs may be found to antagonise 
this apparently unique viral enzyme activity. In this 
regard, M. Green reported that derivatives of rifam- 
picin will inhibit the polymerase atconcentrations 
lower than are required for inactivation of normal bac- 
terial and cellular polymerases. Since rifampicin is al- 
ready in clinical use, this could be a most important 
finding. Gallo has already partially purified the viral 
polymerase from the lymphoblasts of leukaemic blood. 
This shows a 60-70% inhibition with 50/~g/ml of N- 
dimethylrifampicin. These drugs seem to have promise 
in the treatment of leukaemia, provided that the en- 
zyme is important in the maintenance of the leukaemic 
state. 
7.3. Cellular RNA-dependent DNA polymerase? 
The probability of finding specific antiviral drugs 
would sink if it were found that the "viral" polymer- 
ase is in fact cellular. A cellular polymerase could well 
be carried in the virion. Evidence that this might be 
the case is starting the accumulate. Spiegelman finds that 
the polymerase can be detected in a line of rat ascites 
tumour cells which has not shown the presence of any 
virus over several years. Also G. Tocchini-Valenti 
(Naples) reported that ribosomal DNA syntheis in de- 
veloping Xenopus o0cytes is inhibited by a rifampicin 
derivative (AF/ABDMP) which also inhibits RNA-de- 
pendent DNA polymerase but which has no effect on 
the known cellular RNA or DNA polymerases. This re- 
sult suggests that extrachromosomal gene amplification, 
such as the production of ribosomal DNA in oocytes, 
proceeds via an RNA intermediate; whether or not gene 
amplification occurs in other cells remains to be inves- 
tigated. 
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8. Biology of RNA tumour viruses 
Since Temin, the workers in this field have found 
themselves in the spotlight of trendy science. It was 
apparent that until quite recently this research ad 
suffered through lack of attention by molecular bio- 
logists and biochemists. The deficiency isnow more 
than remedied. Temin, far from resting on his laurels, 
continued to speculate. 
8.1. Further Teminism 
H.M. Temin (Wisconsin) suggested the family name 
of Rous viruses for those viruses able to replicate and 
transform cells via a DNA intermediate and went on to 
discuss the origin of these particles. Sites, which he 
called protoviruses, in the chromosomal DNA of som- 
atic cells, but not germ cells, might yield RNA capable 
of passing from cell to cell and acting as a template for 
re-synthesis of DNA. This in turn could be re-integrated 
into chromosomal DNA probably at or alongside the 
protovirus ite. The protovirus hypothesis suggests 
that such a cycle, with its potential for mutation and 
recombination, could have provided amechanism for 
the evolution of RNA tumour viruses. 
8.2. Rous sarcoma virus (RSV} 
This, perhaps the most famous of all tumour vir- 
uses, is still yielding highly significant results with 
regard to virus cancer. Cells from chick embryos are 
either positive or negative for a genetic factor (called 
chfor COFAL) which enables RSV to grow and produce 
infectious particles (normally it requires the presence 
of the helper virus, avian leukosis virus). The work of 
H. Hanafusa et al. (New York Public Health Research 
Institute) has shown that the genetic factor is integrated 
into the host cell chromosome and is inherited in a 
Mendelian manner. It consists of a defective avian 
leukosis genome. Uniquely, the RSV can rescue the 
factor and transmit it from cell to cell. Hanafusa lso 
reported that RNA- and DNA-dependent DNA poly- 
merases are necessary for transformation f cells by 
RSV but not for the maintenance of the transformed 
state. Defective RSV called a (0) cannot ransform 
cells unless these activites are supplied by a helper 
virus. But once integrated into cellular DNA, the viral 
presence is stable. M.A.Baluda (U.C.L.A.) demonstrated 
such integration by hybridization tests. Duesberg re- 
ported that RSV virion RNA can be separated into two 
subunits, called a and b, one of which appears to be as- 
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sociated with transforming ability. Both avian leukaemia 
virus which does not transform, and Peter Vogt's non- 
transforming mutant of RSV lack the a subunit of RNA. 
8.3. Tumor antigens 
Hopefully doctors may one day be using agents to 
attack specifically the integrated viral genome in cells 
of certain types of cancer tissue. Hence the detection 
and identification of the virus present is obviously of 
great importance. W. Sch~fer (Tiibingen) reported the 
discovery of an antigen which is interspecies specific 
for several mammalian leukaemia nd sarcoma viruses. 
Of considerable significance is the finding that the an- 
tigen can be detected in bovine and human leukaemic 
cells in culture and in cultured human breast cancer 
cells. This is further evidence for the viral etiology of 
human leukaemia nd other human cancers. 
In conclusion 
The Italian pharmaceutical company Lepetit must 
be well pleased with the success of their second collo- 
quium, and if the current promise of rifampicin derivat. 
ires as anti-tumour virus agents matures, they should 
be able to afford a third next year. Apart from an over- 
crowded programme, which sometimes did not allow 
much time for discussion, and a fiery monolingual 
French projectionist, he meeting was exceedingly well 
organised (mainly due to the efforts of Professor L.G. 
Silvestri of Lepetit) and the hospitality lavish. 
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